Raphas Co (XKRX:214260) ROCE %

: -17.57% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Raphas Co's annualized ROCE % for the quarter that ended in Dec. 2023 was -17.57%.

Raphas Co ROCE % Historical Data

The historical data trend for Raphas Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphas Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-0.10

-7.51

12.92

-10.94

-8.56

Raphas Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %																-19.20	3.28	-11.76	-11.15	-17.57

Raphas Co ROCE % Calculation

Raphas Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-3849.365	/	( ( (96060.186 - 44377.904)	+	(100404.607 - 62169.091) )	/ 2 )
	=	-3849.365	/	( (51682.282	+	38235.516)	/ 2 )
	=	-3849.365	/	44958.899
	=	-8.56 %

Raphas Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-6968.828	/	( ( (110929.661 - 69838.609)	+	(100404.607 - 62169.091) )	/ 2 )
	=	-6968.828	/	( ( 41091.052	+	38235.516 )	/ 2 )
	=	-6968.828	/	39663.284
	=	-17.57 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Raphas Co (XKRX:214260) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Raphas Co ROCE % Related Terms

Thank you for viewing the detailed overview of Raphas Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Raphas Co (XKRX:214260) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raphas Co Ltd (XKRX:214260) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

62, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, KOR, 07793

Website

http://www.raphas.com

Raphas Co Ltd is engaged in the development of a drug delivery system. The company's products include Acropass, Cosmetics ODM, and Medical Contract Manufacturing Services. Its products are mostly used in biomedical products and all-natural cosmetic materials.

Raphas Co (XKRX:214260) Headlines

No Headlines